| Literature DB >> 33239404 |
Peter M Grace1, Vivianne L Tawfik2, Camilla I Svensson3, Michael D Burton4, Marco L Loggia5, Mark R Hutchinson6.
Abstract
Chronic pain, encompassing conditions, such as low back pain, arthritis, persistent post-surgical pain, fibromyalgia, and neuropathic pain disorders, is highly prevalent but remains poorly treated. The vast majority of therapeutics are directed solely at neurons, despite the fact that signaling between immune cells, glia, and neurons is now recognized as indispensable for the initiation and maintenance of chronic pain. This review highlights recent advances in understanding fundamental neuroimmune signaling mechanisms and novel therapeutic targets in rodent models of chronic pain. We further discuss new technological developments to study, diagnose, and quantify neuroimmune contributions to chronic pain in patient populations.Entities:
Keywords: Fc gamma receptors; Nrf2; TSPO; biomarkers; cannabinoids; sex differences
Mesh:
Substances:
Year: 2020 PMID: 33239404 PMCID: PMC7880288 DOI: 10.1523/JNEUROSCI.1650-20.2020
Source DB: PubMed Journal: J Neurosci ISSN: 0270-6474 Impact factor: 6.167